For the latest updates on our ongoing response to COVID-19, please click here.

Medicine Questions
Investors
Contact
North America South America
Asia
Middle East Africa Australia
Europe

Newsroom

Experiencing CAR T-Cell Therapy and Empowering Others Through Peer-to-Peer Support: Chuck’s Story

Read about Chuck, who received CAR T-cell therapy to treat a form of non-Hodgkin lymphoma and now helps other people living with cancer.

Stories@Gilead - March 05, 2021

Recent Story Posts

Community

Experiencing CAR T-Cell Therapy and Empowering Others Through Peer-to-Peer Support: Chuck’s Story

Stories@Gilead - March 05, 2021
Innovation

Four Questions with Katrin Schoeneweis: Welcoming the MYR Team to Gilead

Stories@Gilead - March 04, 2021
Community

Advocating for Black Women with Triple-Negative Breast Cancer: Ricki’s Story

Stories@Gilead - March 03, 2021

Recent Press Releases

Explore More

View Upcoming Events

Company Statements

2019 Year in Review

 

For more information, contact us.

Phone:
1-800-GILEAD-5 (1-800-445-3235) 1-800-GILEAD-5 (1-800-445-3235)

Email:
public_affairs@gilead.com